Treatment Results

Survival Patients Toxicity Treatment Hospital Country Date
29.2
months
Malignant Pleural Mesothelioma 3 Chemotherapy
Immunotherapy
Center Hospitalier Intercommunal de Creteil France 6/2002
26.8
months
Pleural mesothelioma 5 Chemotherapy
H. Lee Moffitt Cancer Center and Research Institute United States 7/2008
26.0
months
Mesothelioma 3 Chemotherapy
Immunotherapy
Radiation
Surgery
University of Pisa Italy 12/2006
23.0
months
MPM 5 Chemotherapy
Surgery
University Hospital Zurich Switzerland 4/2007
23.0
months
Malignant pleural mesothelioma 3 Biologic therapy
Surgery
New York University School of Medicine United States 8/2008
18.1
months
Malignant Pleural Mesothelioma 5 Radiation
Surgery
University of California, San Francisco United States 12/2002
18.0
months
Malignant Pleural Mesothelioma 3 Immunotherapy
Hopital de la Conception France 11/1998
17.8
months
Malignant Pleural Mesothelioma 5 Biologic therapy
Chemotherapy
Medical University of Lubeck Germany 3/2003
16.8
months
Malignant pleural mesothelioma 4 Chemotherapy
Radiation
Surgery
Memorial Sloan-Kettering Cancer Center United States 6/2009
15.0
months
Malignant Pleural Mesothelioma 3 Immunotherapy
Ospedale S. Spirito Italy 2/2001
14.8
months
Malignant Pleural Mesothelioma 4 Chemotherapy
Newcastle General Hospital United Kingdom 8/2002
14.0
months
Malignant Pleural Mesothelioma 4 Chemotherapy
Ospedale 'Villa Scassi' Italy 12/2007
14.0
months
Malignant pleural mesothelioma 5 Surgery
Memorial Sloan-Kettering Cancer Center United States 3/2008
13.1
months
Malignant pleural mesothelioma 5 Chemotherapy
Surgery
Brigham and Women's Hospital United States 8/2009
13.0
months
Malignant Pleural Mesothelioma 4 Alternative
Chemotherapy
University of Turin Italy 4/2003
13.0
months
Mesothelioma 5 Chemotherapy
Surgery
Brigham and Women's Hospital United States 4/2006
12.7
months
Malignant Pleural Mesothelioma 4 Chemotherapy
Istituto Clinico Humanitas Italy 3/2006
12.7
months
MPM 4 Chemotherapy
Immunotherapy
C. Forlanini Hospital Italy 1/2005
12.4
months
Malignant pleural mesothelioma Surgery
Medical University of Vienna Austria 4/2008
12.1
months
Malignant Pleural Mesothelioma 5 Alternative
Chemotherapy
University of Chicago, Cancer Research Center United States 7/2003
12.0
months
Malignant Pleural Mesothelioma 3 Radiation
Surgery
The University of Texas M. D. Anderson Cancer Center United States 3/2003
11.2
months
MPM 5 Chemotherapy
Emory University School of Medicine United States 5/2005
11.2
months
Malignant pleural mesothelioma 4 Chemotherapy
Sir Charles Gairdner Hospital Australia 8/2002
10.6
months
Malignant Pleural Mesothelioma 4 Chemotherapy
St Bartholomew's Hospital United Kingdom 12/2000
10.5
months
Malignant Mesothelioma 3 Biologic therapy
Chemotherapy
The Royal Marsden Hospital United Kingdom 2/2002
10.3
months
Malignant peritoneal mesothelioma 5 Chemotherapy
Cardarelli Hospital Italy 5/2009
10.1
months
Malignant pleural mesothelioma 4 Chemotherapy
Institut Gustave Roussy France 1/2003
10.1
months
Malignant pleural mesothelioma 4 Chemotherapy
Dana Farber Cancer Institute United States 3/2008
10.0
months
Malignant Mesothelioma 4 Chemotherapy
National University Hospital, Rigshospitalet Denmark 4/1999
10.0
months
Malignant pleural mesothelioma 4 Radiation
Surgery
Memorial Sloan-Kettering Cancer Center United States 10/2001
10.0
months
Malignant Pleural Mesothelioma 5 Biologic therapy
Surgery
The Netherlands Cancer Institute Netherlands 10/2001
9.7
months
Advanced malignant pleural mesothelioma 4 Chemotherapy
Medical University of Gdansk Poland 4/2008
9.6
months
Malignant Mesothelioma 5 Chemotherapy
University of Chicago Medical Center United States 11/1999
9.6
months
Malignant pleural mesothelioma 4 Chemotherapy
Charing Cross Hospital United Kingdom 5/2008
9.5
months
Malignant pleural mesothelioma 5 Chemotherapy
Leeds General Infirmary United Kingdom 5/2008
9.4
months
Malignant Pleural Mesothelioma 4 Chemotherapy
University Hospital Rotterdam Netherlands 2/2002
9.3
months
MPM 5 Chemotherapy
University of Chicago United States 6/2005
9.3
months
Malignant Pleural Mesothelioma 4 Chemotherapy
Immunotherapy
Istituto Clinico Humanitas Italy 8/2001
9.3
months
Malignant Pleural Mesothelioma 4 Alternative
Chemotherapy
University of Chicago, Cancer Research Center United States 7/2003
9.0
months
Malignant Pleural Mesothelioma 2 Immunotherapy
St. Bartholomew's Hospital United Kingdom 1/2001
8.8
months
MPM 4 Chemotherapy
St. Bartholomew's Hospital United Kingdom 2/2005
8.8
months
Malignant Pleural Mesothelioma 4 Chemotherapy
University Hospital Vrije Universiteit Netherlands 11/1997
8.7
months
Malignant Pleural Mesothelioma 1 Radiation
Sir Charles Gairdner Hospital Australia 7/2004
8.5
months
Malignant Pleural Mesothelioma 4 Chemotherapy
The University of Texas M.D. Anderson Cancer Center United States 8/2000
8.2
months
Malignant Pleural Mesothelioma 4 Chemotherapy
Erasmus Medical Center Netherlands 4/2002
8.0
months
Malignant Pleural Mesothelioma 4 Chemotherapy
University of Turin Italy 4/2003
7.6
months
MPM 3 Biologic therapy
Netherlands Cancer Institute Netherlands 5/2005
7.0
months
Malignant pleural mesothelioma 3 Chemotherapy
The Netherlands Cancer Institute Netherlands 2/2003
7.0
months
Malignant Mesothelioma 5 Chemotherapy
Columbia University United States 7/2003
6.8
months
Advanced mesothelioma 5 Chemotherapy
Washington University School of Medicine United States 3/2005
6.6
months
Malignant Mesothelioma 4 Chemotherapy
University of Chicago Medical Center United States 11/1999
6.0
months
Unresectable Malignant Mesothelioma 4 Chemotherapy
Alfacell Corp. United States 1/2002
5.8
months
Malignant pleural mesothelioma 4 Biologic therapy
Dana-Farber Cancer Institute United States 6/2008
4.9
months
Malignant Mesothelioma 5 Chemotherapy
Ohio State University Comprehensive Cancer Center United States 5/2004
4.8
months
Malignant Mesothelioma 5 Chemotherapy
Scripps Clinic United States 11/2001
4.7
months
Malignant Mesothelioma 5 Chemotherapy
University of Chicago Medical Center United States 2/2001
3.2
months
MPM 3 Chemotherapy
San Matteo University Hospital Italy 6/2005
N/R Mesothelioma 3 Alternative
University of Texas, M. D. Anderson Cancer Center United States 3/2001
N/R MPM 4 Biologic therapy
Erasmus Medical Center Netherlands 2/2005
? Mesothelioma 4 Immunotherapy
Memorial Hermann Hospital United States 12/2002
? Mesothelioma 4 Biologic therapy
Massachusetts General Hospital United States 2/2001
? Malignant Pleural Mesothelioma 4 Chemotherapy
IST Istituto Nazionale per la Ricerca sul Cancro Italy 11/2001
? Mesothelioma 4 Chemotherapy
University of Minnesota Medical School United States 1/2002

Have questions about mesothelioma?

If you want answers right now call our Mesothelioma Resource Specialist - Abby Palmer, MSW.

She takes calls throughout the day and early evening.  Her number is: 619-261-7922.
She is not a doctor and does not provide medical advice.



DISCLAIMER: Surviving Mesothelioma® is registered with the United States Patent and Trademark Office by Cancer Monthly, Inc. and the website is owned and managed by Cancer Monthly Inc. All of the information provided on this website is for informational purposes only. Neither Cancer Monthly nor this website renders medical advice or professional services. The information provided by Abby Palmer or any other employee or contractor of Cancer Monthly, Inc. is not to be considered medical advice and is not intended to replace consultation with a qualified medical professional. You should consult a qualified health care provider for medical advice and answers to personal health questions. The responsibility of your disease management plan is with your treating physicians and you should only follow your treating physician’s advice. DO NOT change or modify your disease management plan on your own without consulting your treating physicians. This website is not a substitute for professional medical advice, examination, diagnosis or treatment. This website should not be used for diagnosing or treating a health problem or disease and it is not a substitute for professional care. You should always seek the advice of your physician or other qualified health professional before starting any new treatment or making any changes to an existing treatment. You should not delay in seeking or disregard medical advice based on information on this website. Some information may be out of date. The information on this website is intended to convey general information only. It should not be construed as legal advice or opinion. This website and its contents are not intended to create an attorney-client relationship. You should not act on or rely on any information on this website without seeking the advice of an attorney. You are encouraged to promptly speak to legal counsel to identify and protect your legal rights and any deadlines for filing a claim or lawsuit. People who request a free book may be called to verify their address and to introduce other mesothelioma resources that are available.